The duration of antibiotic therapy for GN-BSIs varied across US hospitals and was commonly longer than 10 days, including in patients with uncomplicated bacteremia.

This retrospective observational analysis aims to characterize carbapenemase-producing bacteria (CPB) in Latin America and the Caribbean (LAC), with a focus on resistance mechanisms, using data from ...